Bharat Biotech's homegrown COVID-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the Indian company said on Wednesday.
The interim analysis was based on 43 recorded cases of COVID-19 in the trial of 25,800 participants, conducted in partnership with the Indian government's medical research body.
Thirty-six of the 43 cases were recorded in participants who received a placebo, compared with seven cases in people who were given the Bharat Biotech vaccine, pointing to an efficacy rate of 80.6%, the company said.
India had approved the vaccine, branded COVAXIN, in January without late-stage efficacy data, raising questions about its effectiveness.
India's vaccination drive, currently underway, includes COVAXIN and a vaccine developed by Oxford University and AstraZeneca.
Earlier this week, Indian Prime Minister Narendra Modi was inoculated with the first dose of COVAXIN.
A man missing for more than 26 years has been found alive in his neighbour's cellar, just a few hundred metres from his family home. Omar bin Omran was reportedly kidnapped as a teenager and was discovered on Sunday.
China will always be a good neighbor, friend and partner of mutual trust with Russia, the state television quoted China president Xi Jinping as saying, as he mets Russian president Vladimir Putin.
Slovak Prime Minister Robert Fico is no longer in a life-threatening condition after he was shot in an assassination attempt when leaving a government meeting on Wednesday, a government minister said.
US President Joe Biden and Republican rival Donald Trump on Wednesday agreed to face off in two debates on June 27 and Sept. 10, setting up the highest stakes moments yet of the race for the White House.
The number of people killed by weekend flash floods and mud slides in Indonesia's West Sumatra province has risen to 67 and 20 are still missing, authorities said on Thursday, as the government plans to relocate survivors to safer areas.